FSD Pharma (@FsdPharma) (#Nasdaq: $HUGE | #CSE: $HUGE) Receives U.S. FDA Approval to design a Phase 2a #ClinicalTrial to Treat Patients with Suspected or Confirmed #COVID19 Diagnosis [https://t.co/BdHxTmDsXr]

#investing #stocks #stockmarket #trading #investors #news #coronavirus https://t.co/veCEY6nESJ